WuXi XDC eyes IPO to boost ADC, bioconjugate manufacturing footprint
WuXi XDC is going to list on the Hong Kong Exchange on Nov. 17, with plans to raise approximately HK$3.4 billion ($437.7 million) to expand …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
